Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins B-raf | 12 | 2023 | 2057 | 1.730 |
Why?
|
Melanoma | 25 | 2024 | 5709 | 1.610 |
Why?
|
Microphthalmia-Associated Transcription Factor | 9 | 2022 | 259 | 1.290 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2024 | 5305 | 1.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2019 | 1406 | 1.060 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 198 | 0.810 |
Why?
|
Antitussive Agents | 2 | 2011 | 18 | 0.770 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2022 | 8552 | 0.630 |
Why?
|
Plant Extracts | 2 | 2011 | 498 | 0.580 |
Why?
|
RNA Stability | 1 | 2019 | 329 | 0.580 |
Why?
|
Cough | 2 | 2011 | 594 | 0.570 |
Why?
|
Oxidative Phosphorylation | 2 | 2014 | 496 | 0.480 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 318 | 0.480 |
Why?
|
Melanocytes | 7 | 2016 | 509 | 0.440 |
Why?
|
Protein Kinase Inhibitors | 8 | 2024 | 5672 | 0.440 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2019 | 1246 | 0.430 |
Why?
|
Heat-Shock Proteins | 2 | 2013 | 795 | 0.400 |
Why?
|
Vitex | 1 | 2011 | 2 | 0.390 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | 2003 | 34 | 0.390 |
Why?
|
Uveal Neoplasms | 2 | 2024 | 341 | 0.370 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2811 | 0.370 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 718 | 0.360 |
Why?
|
Glycolysis | 1 | 2014 | 835 | 0.340 |
Why?
|
Phytotherapy | 1 | 2011 | 296 | 0.320 |
Why?
|
Cell Line, Tumor | 15 | 2024 | 16986 | 0.320 |
Why?
|
Skin Neoplasms | 5 | 2024 | 5821 | 0.320 |
Why?
|
Vibrio vulnificus | 1 | 2006 | 10 | 0.270 |
Why?
|
Vibrio Infections | 1 | 2006 | 33 | 0.260 |
Why?
|
Fasciitis, Necrotizing | 1 | 2006 | 79 | 0.250 |
Why?
|
Apoptosis | 6 | 2020 | 9489 | 0.240 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2024 | 34 | 0.240 |
Why?
|
Ploidies | 1 | 2024 | 285 | 0.230 |
Why?
|
Caspase 9 | 1 | 2024 | 185 | 0.230 |
Why?
|
Mitochondria | 2 | 2014 | 3624 | 0.220 |
Why?
|
Seafood | 1 | 2006 | 393 | 0.210 |
Why?
|
Neoplasms | 7 | 2020 | 22173 | 0.200 |
Why?
|
Diabetic Neuropathies | 2 | 2003 | 405 | 0.200 |
Why?
|
Immunotherapy | 4 | 2021 | 4652 | 0.190 |
Why?
|
Transcription Factors | 4 | 2021 | 12129 | 0.190 |
Why?
|
Milk Proteins | 1 | 2002 | 163 | 0.190 |
Why?
|
Leg | 1 | 2006 | 1088 | 0.180 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.180 |
Why?
|
Sural Nerve | 1 | 2000 | 105 | 0.180 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 441 | 0.180 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2020 | 37 | 0.180 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2001 | 655 | 0.180 |
Why?
|
Signal Transduction | 9 | 2020 | 23447 | 0.170 |
Why?
|
Tristetraprolin | 1 | 2019 | 38 | 0.170 |
Why?
|
Neurofibromin 1 | 1 | 2020 | 190 | 0.160 |
Why?
|
Bacteremia | 1 | 2006 | 980 | 0.160 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 294 | 0.160 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 1999 | 225 | 0.160 |
Why?
|
Respiratory Muscles | 1 | 1999 | 142 | 0.150 |
Why?
|
Indoles | 4 | 2014 | 1833 | 0.150 |
Why?
|
Mutation | 10 | 2023 | 30054 | 0.150 |
Why?
|
Serine | 1 | 2002 | 830 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2021 | 659 | 0.150 |
Why?
|
Point Mutation | 2 | 2020 | 1595 | 0.140 |
Why?
|
Conserved Sequence | 1 | 2001 | 1163 | 0.140 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3877 | 0.140 |
Why?
|
Erythropoietin | 1 | 2002 | 719 | 0.140 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 517 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 11742 | 0.140 |
Why?
|
MAP Kinase Signaling System | 4 | 2014 | 1486 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1609 | 0.140 |
Why?
|
Animals | 21 | 2024 | 168467 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.140 |
Why?
|
Sulfonamides | 4 | 2014 | 1978 | 0.140 |
Why?
|
Mice, Nude | 2 | 2020 | 3614 | 0.130 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 344 | 0.130 |
Why?
|
Muscular Dystrophies | 1 | 1999 | 390 | 0.130 |
Why?
|
Humans | 50 | 2024 | 761572 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 2 | 2022 | 3165 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 784 | 0.130 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 891 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3603 | 0.130 |
Why?
|
Mice | 14 | 2024 | 81533 | 0.130 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13642 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 370 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 350 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2020 | 516 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 561 | 0.120 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 4251 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1469 | 0.120 |
Why?
|
Thyroid Diseases | 1 | 2017 | 386 | 0.120 |
Why?
|
Cell Cycle | 1 | 2002 | 2932 | 0.110 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.110 |
Why?
|
HeLa Cells | 1 | 2020 | 3094 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1410 | 0.110 |
Why?
|
Drug Resistance | 1 | 2020 | 1596 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 549 | 0.110 |
Why?
|
Creatinine | 1 | 2019 | 1899 | 0.110 |
Why?
|
Adaptation, Biological | 1 | 2014 | 147 | 0.110 |
Why?
|
Suntan | 1 | 2012 | 17 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2898 | 0.110 |
Why?
|
Salvage Therapy | 1 | 1999 | 1264 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1608 | 0.100 |
Why?
|
Cell Nucleus | 2 | 2020 | 2910 | 0.100 |
Why?
|
Trans-Activators | 1 | 2002 | 2856 | 0.100 |
Why?
|
YY1 Transcription Factor | 1 | 2012 | 60 | 0.100 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1999 | 1374 | 0.100 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2013 | 293 | 0.100 |
Why?
|
Ballota | 1 | 2011 | 1 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1881 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.100 |
Why?
|
Pigmentation | 1 | 2012 | 144 | 0.100 |
Why?
|
Lethal Dose 50 | 1 | 2011 | 72 | 0.100 |
Why?
|
Hair Color | 1 | 2012 | 131 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1233 | 0.100 |
Why?
|
Male | 21 | 2024 | 360842 | 0.100 |
Why?
|
Cell Line, Transformed | 1 | 2013 | 866 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2019 | 12794 | 0.100 |
Why?
|
Dextromethorphan | 1 | 2011 | 37 | 0.100 |
Why?
|
Codeine | 1 | 2011 | 51 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2002 | 687 | 0.090 |
Why?
|
Medicine, Traditional | 1 | 2011 | 88 | 0.090 |
Why?
|
Genomics | 3 | 2024 | 5821 | 0.090 |
Why?
|
Neural Conduction | 2 | 2003 | 441 | 0.090 |
Why?
|
Pakistan | 1 | 2011 | 293 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 4513 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 641 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 946 | 0.090 |
Why?
|
Base Sequence | 2 | 2019 | 12441 | 0.080 |
Why?
|
Biogenic Monoamines | 1 | 2009 | 50 | 0.080 |
Why?
|
Particle Size | 1 | 2013 | 1648 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2450 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1762 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4319 | 0.080 |
Why?
|
Gene Amplification | 1 | 2013 | 1089 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18253 | 0.080 |
Why?
|
Drug Design | 1 | 2013 | 1048 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1213 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2021 | 9610 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3713 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2014 | 571 | 0.070 |
Why?
|
Aged | 13 | 2024 | 169310 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3303 | 0.070 |
Why?
|
Korea | 1 | 2006 | 98 | 0.070 |
Why?
|
Ceftazidime | 1 | 2006 | 57 | 0.070 |
Why?
|
Middle Aged | 16 | 2024 | 220920 | 0.070 |
Why?
|
Neoplasm Metastasis | 4 | 2024 | 4915 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1334 | 0.060 |
Why?
|
Cytokines | 1 | 2021 | 7396 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10194 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6132 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
Female | 18 | 2024 | 392686 | 0.060 |
Why?
|
Aging | 1 | 2003 | 8711 | 0.060 |
Why?
|
Genomic Structural Variation | 1 | 2024 | 68 | 0.060 |
Why?
|
Doxycycline | 1 | 2006 | 344 | 0.060 |
Why?
|
Cooking | 1 | 2006 | 315 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7858 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2449 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2827 | 0.050 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2002 | 20 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2003 | 206 | 0.050 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2002 | 149 | 0.050 |
Why?
|
Receptors, Erythropoietin | 1 | 2002 | 144 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2226 | 0.050 |
Why?
|
Azathioprine | 1 | 2003 | 354 | 0.050 |
Why?
|
Phthalazines | 1 | 2024 | 383 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2002 | 265 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 813 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2218 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2024 | 732 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 489 | 0.050 |
Why?
|
Peptides | 1 | 2013 | 4358 | 0.050 |
Why?
|
Growth Hormone | 1 | 2003 | 569 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2001 | 77 | 0.050 |
Why?
|
Adult | 12 | 2024 | 221203 | 0.050 |
Why?
|
Tyrosine | 2 | 2002 | 1440 | 0.050 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2001 | 110 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2002 | 305 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3449 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2002 | 341 | 0.040 |
Why?
|
Trihexosylceramides | 1 | 2000 | 31 | 0.040 |
Why?
|
Aminopyridines | 1 | 2024 | 573 | 0.040 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2020 | 13446 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9031 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2002 | 3597 | 0.040 |
Why?
|
Mitoxantrone | 1 | 1999 | 148 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2561 | 0.040 |
Why?
|
Life Tables | 1 | 1999 | 364 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14032 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2001 | 2748 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4937 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2003 | 836 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2003 | 479 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 2 | 2014 | 271 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.040 |
Why?
|
Gene Fusion | 1 | 2022 | 356 | 0.040 |
Why?
|
Jejunum | 1 | 2001 | 472 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2002 | 560 | 0.040 |
Why?
|
Blotting, Western | 2 | 2006 | 5035 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2003 | 664 | 0.040 |
Why?
|
Enterotoxins | 1 | 2000 | 366 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 558 | 0.040 |
Why?
|
Prednisone | 1 | 2003 | 1563 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2001 | 4174 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12975 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14416 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 386 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1125 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17904 | 0.040 |
Why?
|
Electrophysiology | 1 | 2000 | 1262 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2002 | 871 | 0.040 |
Why?
|
Cytarabine | 1 | 1999 | 698 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2003 | 1036 | 0.040 |
Why?
|
Phosphorylation | 3 | 2006 | 8321 | 0.040 |
Why?
|
Cytoplasm | 1 | 2002 | 1510 | 0.040 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2003 | 952 | 0.040 |
Why?
|
Thyrotoxicosis | 1 | 2017 | 85 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2001 | 2264 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58986 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 12947 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2002 | 897 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10090 | 0.030 |
Why?
|
Cell Survival | 2 | 2020 | 5791 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2003 | 874 | 0.030 |
Why?
|
Hippocampus | 1 | 2009 | 3766 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2001 | 1699 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12463 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2014 | 18965 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 1935 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2021 | 80646 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13382 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2002 | 6534 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4465 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1999 | 673 | 0.030 |
Why?
|
Benzocycloheptenes | 1 | 2014 | 9 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 1999 | 1386 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2000 | 932 | 0.030 |
Why?
|
Neutropenia | 1 | 1999 | 885 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1567 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1456 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 1999 | 1682 | 0.030 |
Why?
|
Remission Induction | 1 | 1999 | 2397 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2523 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 1989 | 0.030 |
Why?
|
Cisplatin | 1 | 1999 | 1652 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 1998 | 1229 | 0.030 |
Why?
|
Monophenol Monooxygenase | 1 | 2012 | 72 | 0.030 |
Why?
|
Oximes | 1 | 2014 | 303 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2425 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2017 | 668 | 0.030 |
Why?
|
alpha-MSH | 1 | 2012 | 71 | 0.030 |
Why?
|
Immunity | 1 | 2018 | 996 | 0.030 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2006 | 64684 | 0.020 |
Why?
|
Respiration | 1 | 1999 | 1657 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2020 | 0.020 |
Why?
|
Gene Deletion | 1 | 2020 | 2665 | 0.020 |
Why?
|
Dexamethasone | 1 | 1999 | 1948 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2024 | 3617 | 0.020 |
Why?
|
Rats | 3 | 2009 | 23741 | 0.020 |
Why?
|
Drug Discovery | 1 | 2020 | 1051 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13510 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.020 |
Why?
|
Pyrimidinones | 1 | 2014 | 385 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 1999 | 1182 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1118 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1999 | 4853 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2046 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2002 | 3113 | 0.020 |
Why?
|
Leukemia | 1 | 1999 | 1522 | 0.020 |
Why?
|
Cell Line | 2 | 2002 | 15601 | 0.020 |
Why?
|
Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
Anilides | 1 | 2014 | 411 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 1999 | 1200 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2001 | 17635 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 578 | 0.020 |
Why?
|
Melanins | 1 | 2012 | 290 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7593 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.020 |
Why?
|
Collagen | 1 | 1999 | 2638 | 0.020 |
Why?
|
Cell Lineage | 2 | 2012 | 2556 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5439 | 0.020 |
Why?
|
Models, Biological | 2 | 2003 | 9469 | 0.020 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 73 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5799 | 0.020 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2009 | 54 | 0.020 |
Why?
|
Serotonin Agents | 1 | 2009 | 29 | 0.020 |
Why?
|
Fenfluramine | 1 | 2009 | 58 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 1999 | 6815 | 0.020 |
Why?
|
Pneumonia | 1 | 2021 | 2143 | 0.020 |
Why?
|
Stem Cells | 1 | 2002 | 3523 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2014 | 1069 | 0.020 |
Why?
|
Kainic Acid | 1 | 2009 | 203 | 0.020 |
Why?
|
Isoproterenol | 1 | 2009 | 395 | 0.020 |
Why?
|
Pyridones | 1 | 2014 | 809 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
Biopsy | 1 | 2000 | 6766 | 0.020 |
Why?
|
Carbachol | 1 | 2009 | 223 | 0.020 |
Why?
|
Keratinocytes | 1 | 2012 | 791 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
Quinolines | 1 | 2014 | 764 | 0.020 |
Why?
|
Central Nervous System Agents | 1 | 2009 | 75 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1180 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3517 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4580 | 0.020 |
Why?
|
Radiography | 1 | 1999 | 6965 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3767 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22172 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 7407 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41493 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12725 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1756 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2009 | 369 | 0.020 |
Why?
|
Norepinephrine | 1 | 2009 | 897 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3848 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
Sepsis | 1 | 1999 | 2585 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14666 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1848 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10553 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.020 |
Why?
|
Time Factors | 2 | 2006 | 39970 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
Serotonin | 1 | 2009 | 1041 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10448 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2009 | 1736 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1897 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9177 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2735 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 855 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2006 | 852 | 0.010 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2002 | 46 | 0.010 |
Why?
|
GRB2 Adaptor Protein | 1 | 2002 | 101 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 73 | 0.010 |
Why?
|
Immunoblotting | 1 | 2006 | 1646 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2875 | 0.010 |
Why?
|
Adenoviridae | 1 | 2006 | 1085 | 0.010 |
Why?
|
Dopamine | 1 | 2009 | 1607 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 2002 | 456 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2819 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5790 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12954 | 0.010 |
Why?
|
Phenylalanine | 1 | 2002 | 366 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59255 | 0.010 |
Why?
|
Shiga Toxins | 1 | 2000 | 40 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2002 | 412 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7581 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2000 | 188 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39107 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4575 | 0.010 |
Why?
|
Kinetics | 1 | 2006 | 6374 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2000 | 837 | 0.010 |
Why?
|
ras Proteins | 1 | 2002 | 1054 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4124 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3442 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1999 | 2180 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22176 | 0.010 |
Why?
|
Cell Death | 1 | 2000 | 1679 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2000 | 2065 | 0.010 |
Why?
|
Brain | 1 | 2001 | 27120 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9353 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15936 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 5774 | 0.010 |
Why?
|
Child | 1 | 2020 | 80156 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4615 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2000 | 2822 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36429 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 3032 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 11904 | 0.000 |
Why?
|
Escherichia coli | 1 | 2000 | 4217 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6032 | 0.000 |
Why?
|